Blackstone Inc’s GeneDx Holdings WGS Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2023
Q3
Sell
-80,487
Closed -$900K 169
2023
Q2
$900K Hold
80,487
﹤0.01% 129
2023
Q1
$900K Hold
80,487
﹤0.01% 125
2022
Q4
$900K Hold
80,487
﹤0.01% 106
2022
Q3
$900K Buy
+80,487
New +$3.69M ﹤0.01% 122
2022
Q1
Sell
-80,487
Closed -$2.47M 303
2021
Q4
$2.47M Hold
80,487
0.01% 284
2021
Q3
$8.12M Buy
+80,487
New +$27.6M 0.02% 176

Other funds holding WGS

Blackstone Inc's WGS Position: Q4 2024 in Review

Blackstone Inc sold out of GeneDx Holdings (WGS) in Q4 2024, closing a stake of 420,715 shares — an estimated $17.9M sold.

Blackstone Inc first reported a position in WGS in Q4 2020 and held it in 16 quarters. The position peaked at $191M in Q3 2021. 199 funds tracked by Wall St. Rank hold WGS as of Q4 2024.

  • Blackstone Inc reported no remaining GeneDx Holdings position as of Q4 2024 after selling out during the quarter.
  • Blackstone Inc sold 420,715 GeneDx Holdings shares in Q4 2024, an estimated $17.9M.
  • Blackstone Inc first reported a position in GeneDx Holdings in Q4 2020 and held it in 16 quarters.
  • Blackstone Inc's GeneDx Holdings position peaked at $191M in Q3 2021.
  • 199 funds tracked by Wall St. Rank held GeneDx Holdings as of Q4 2024.

Based on Blackstone Inc's 13F filing for Q4 2024, filed 14 Feb 2025.